Xinrui Mao
-
- Breast Cancer Treatment Studies 2
- Cancer-related molecular mechanisms research 2
-
- Cancer Immunotherapy and Biomarkers 7
- Cancer Cells and Metastasis 5
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 6
-
- RNA modifications and cancer 2
- RNA and protein synthesis mechanisms 2
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Communications (1 paper)Advanced Science (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Xinrui Mao
13 papers receiving 299 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 141
- Oncology 106
- Immunology 71
- Molecular Biology 141
- Hepatology 11
Countries citing papers authored by Xinrui Mao
This map shows the geographic impact of Xinrui Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinrui Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinrui Mao more than expected).
Fields of papers citing papers by Xinrui Mao
This network shows the impact of papers produced by Xinrui Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinrui Mao. The network helps show where Xinrui Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinrui Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 26 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 53 | |
| 9 | 2021 | 63 | |
| 10 | 2021 | 40 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 56 | |
| 13 | 2020 | 19 |
About Xinrui Mao
Xinrui Mao is a scholar working on Oncology, Cancer Research and Immunology, having authored 13 papers that have together received 301 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers), CAR-T cell therapy research (3 papers), RNA modifications and cancer (2 papers), Breast Cancer Treatment Studies (2 papers), Cancer-related molecular mechanisms research (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Cancer Research (141 citations), Oncology (106 citations) and Immunology (71 citations). Xinrui Mao has collaborated with scholars based in China and South Korea. Frequent co-authors include Shui Wang, Xiaoan Liu, Ge Ma, Tiansong Xia, Xu Han, Muxin Yu, Wenbin Zhou, Qiang Ding, Nan Che and Wen Qiu. Their work appears in journals such as Nature Communications, Advanced Science and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.